XML 31 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 145,647 $ 123,554
Marketable securities 400,576 516,598
Prepaid expenses and other current assets 8,463 11,143
Total current assets 554,686 651,295
Restricted cash 284 280
Marketable securities, non-current 16,506 70,117
Other investments 32,001 44,924
Property and equipment, net 102,654 123,023
Operating lease right-of-use assets 39,663 43,242
Other non-current assets 4,235 4,680
Total assets 750,029 937,561
Current liabilities:    
Accounts payable 4,817 3,917
Accrued liabilities and other current liabilities 28,126 28,755
Success payment liabilities 1,576 4,356
Total current liabilities 34,519 37,028
Operating lease liabilities, non-current 56,894 63,168
Other non-current liabilities 3,664 4,113
Total liabilities 95,077 104,309
Commitments and contingencies (Note 16)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 10,000 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022 0 0
Common stock, $0.0001 par value; 500,000 shares authorized at December 31, 2023 and 2022, respectively; 253,958 and 249,567 shares issued and outstanding at December 31, 2023 and 2022, respectively 25 25
Additional paid-in capital 1,657,133 1,608,306
Accumulated other comprehensive loss (94) (7,599)
Accumulated deficit (1,002,112) (767,480)
Total stockholders’ equity 654,952 833,252
Total liabilities and stockholders’ equity $ 750,029 $ 937,561
Common stock authorized (in shares) 500,000,000 500,000,000
Preferred stock authorized (in shares) 10,000,000 10,000,000